Royal Bank Of Canada Surrozen, Inc. Transaction History

Royal Bank Of Canada

  • $471 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$0.44 - $0.89 $46 - $93
-105 Reduced 17.83%
484 $0
Q2 2023

Aug 14, 2023
BUY
$0.55 - $0.72 $323 - $424
589 New
589 $0

Others Institutions Holding SRZN

# of Institutions
3
Shares Held
4.52M
Call Options Held
0
Put Options Held
0
View Full List

About Surrozen, Inc.

SRZN Quotes by TradingView
  • Ticker SRZN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,122,900
  • Market Cap $430M
  • Description
  • Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, a...
More about SRZN
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email